Big pharma and social responsibility.

Hawkes, Christopher H; Giovannoni, Gavin; Levy, Michael Z.; Lechner-Scott, Jeanette; Waubant, Emmanuelle

doi:10.1016/j.msard.2020.102069

Record: found
Abstract: not found
Article: not found

Big pharma and social responsibility.

Author(s): Christopher H Hawkes , Gavin Giovannoni , Michael Levy , Jeanette Lechner-Scott , Emmanuelle Waubant

Publication date (Electronic): Apr 2020

Journal: Multiple sclerosis and related disorders

Publisher: Elsevier BV

Keywords: Biotech, Disease-modifying treatment, Generic, Interview, Multiple sclerosis, NICE

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Mult Scler Relat Disord

Title: Multiple sclerosis and related disorders

Publisher: Elsevier BV

ISSN (Electronic): 2211-0356

ISSN (Print): 2211-0348

Publication date (Electronic): Apr 2020

Volume: 39

Article

Publisher Item ID: S2211-0348(20)30145-0

DOI: 10.1016/j.msard.2020.102069

PubMed ID: 32334821

SO-VID: 84211b1b-550e-44d7-9c5f-c568585cb9ff

History

Keywords: Interview,Disease-modifying treatment,Biotech,Multiple sclerosis,NICE,Generic

Data availability:

Keywords: Interview, Disease-modifying treatment, Biotech, Multiple sclerosis, NICE, Generic

Big pharma and social responsibility.

Read this article at

Related collections

Karger: Neurology and Neuroscience

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 2,801

Cited by 1